Substanzen · Phenethylamin-Derivate
4F-MPH
- Bevorzugter Name
- 4F-MPH
- IUPAC-Name
- methyl (2R)-2-(4-fluorophenyl)-2-[(2R)-piperidin-2-yl]acetate
- CAS-Nummer der Stammverbindung (Referenz)
- 1354631-33-6
- Summenformel
- C14H18FNO2
- Molekulargewicht
- 251.3 g/mol
- InChIKey
- XISBAJBPDVRSPG-CHWSQXEVSA-N
- PubChem
- CID 52944002
- Quelle
- PubChem
- Geprüfte Synonyme und Katalogkürzel
-
4-Fluoromethylphenidate 4FMPH 4F MPH threomethylphenidate-4F
Passende Artikel im aktuellen Shop-Katalog
Geprüftes Pharmakologie- & Toxikologie-Dossier
4F-MPH
Rezeptor-Telemetrie & Wirkmechanismus
4F-MPH is a fluorinated analogue of methylphenidate and a dopamine/norepinephrine reuptake inhibitor, not a substrate releaser like amphetamine. Fluorination increases potency relative to methylphenidate, which is why the PsychonautWiki common oral band is only 10–15 mg. The reference IUPAC is the (2R,2'R) threo form, methyl (2R)-2-(4-fluorophenyl)-2-[(2R)-piperidin-2-yl]acetate. The subjective feel is focused stimulation, anxiety at the top of the range, and a long residual tail rather than an entactogenic roll.
Biotransformation & Active Metabolites
Like methylphenidate, the ester can be hydrolyzed to the inactive ritalinic-acid analogue. It is not a prodrug of amphetamine and it is not isopropylphenidate.
Zeitliche Pharmakokinetik
Potent, functional NDRI stimulant. Focus and wakefulness, little serotonin warmth, a sharp anxiety edge when pushed, and hours of residual stimulation.
- Onset 30–60 minutes
- Peak Window 2–4 hours
- Total Window 4–8 hours
- Residual / Half-Life After-effects 5–10 hours. The ester hydrolysis product is not an active 'second wind'.
Threshold under 5 mg, light 5–10 mg, common 10–15 mg, strong 15–20 mg, heavy above 20 mg. The entire useful span is about 15 mg wide. mucosal exposure common is 8–14 mg and shorter; it is harsher and not required to describe the oral window. A methylphenidate-sized dose is already a heavy 4F-MPH dose.
Quantitatives Wirkungsspektrum (Literaturdaten)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
under 5 mg
A small increase in alertness.
Slight dry mouth.
5–10 mg
Functional focus and wakefulness with little elevated dopaminergic tone.
Appetite suppression and a mild pulse increase.
10–15 mg
Clear stimulation, task focus, and talkativeness that can tip into scatter.
Tachycardia, cold hands, bruxism, and sweating.
15–20 mg
Anxiety, forced wakefulness, and irritable focus rather than better concentration.
Pronounced vasoconstriction, tremor, and a long insomnia tail.
20 mg+
Agitation, paranoia, and compulsive repeated exposure.
Hypertensive strain, chest discomfort, severe insomnia, and seizure risk with tramadol or an MAOI.
Wechselwirkungsmatrix — Niemals kombinieren
Lebensgefahr — Niemals kombinieren
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
Adds extreme vasoconstriction and seizure risk on top of an already raised heart rate and blood pressure.
Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.
Hohes Risiko — Vermeiden
Additive tachycardia, hypertension, bruxism, and post-session anxiety without restoring a faded peak.
The stimulant hides sedation. When it drops, the depressant remains.
Vorsicht / Abschwächung
Additive norepinephrine/dopamine reuptake block. IPPH common is 15–25 mg and is not a top-up for 4F-MPH.
May change how fast the oral dose arrives. It does not make a 20 mg dose a light one.
Isomeren- & Strukturvergleich
4F-MPH is the potent fluorinated methylphenidate: common oral 10–15 mg, heavy above 20 mg, 4–8 hours plus a 5–10 hour tail. IPPH is the isopropyl ester, less sharp, common 15–25 mg, total about 3.5–6 hours. Methylphenidate tablet habits are larger than this compound's heavy line. Neither phenidate is an entactogen; 4-FA and 5-MAPB are the wrong family and the wrong interactions.
Stabilität & Lagerung
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
Stimulant tolerance with cross-tolerance to other NDRIs and amphetamines. Halves over roughly 3–7 days and approaches baseline in 1–2 weeks of abstinence. Psychological dependence and a crash of fatigue and low mood are expected. It is not an opioid withdrawal. Chasing the 2–4 hour peak with a second 10 mg is how the heavy zone is reached.
Chemische Struktur und Molekülprofil
4F-MPH (methyl (2R)-2-(4-fluorophenyl)-2-[(2R)-piperidin-2-yl]acetate) ist eine Referenzverbindung aus der Stoffklasse Phenethylamin-Derivate mit der Summenformel C14H18FNO2 und einer molaren Masse von 251.3 g/mol. Die Stammverbindung wird unter der CAS-Nummer 1354631-33-6 sowie in der NCBI-PubChem-Datenbank unter CID 52944002 geführt (Standard-InChIKey: XISBAJBPDVRSPG-CHWSQXEVSA-N).
Quellen
- PubChem — PubChem (2026-11-12)
Referenztoxikologie und Sicherheitsprofil
Laut dokumentierten Referenzdaten (PubChem / PsychonautWiki, CC BY 4.0) gehört 4F-MPH zur chemischen Klasse Substituted phenidates. Substituiertes Phenethylamin-Derivat; dokumentierte Sicherheitshinweise nennen Wechselwirkungen mit MAO-Hemmern, Tramadol und Lithiumsalzen. Beim Umgang im Labor sind geeignete persönliche Schutzausrüstung und das Sicherheitsdatenblatt (SDB) zu beachten.
Quellen
- PubChem — PubChem (2026-11-12)
Analytischer Verwendungszweck und Laborhinweis
Dieses Datenblatt dient ausschließlich der chemischen, analytischen und toxikologischen Dokumentation. Das Material ist nicht für den menschlichen Verzehr bestimmt. Ein Forschungshinweis begründet keinen Rechtsstatus.
Quellen
- Gesetze im Internet — Neue-psychoaktive-Stoffe-Gesetz (NpSG) & BtMG — Bundesministerium der Justiz (2026-11-12)